These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 17721326

  • 1. Microsatellite analysis in serum DNA as a diagnostic tool for distinction of patients with unknown pancreatic masses.
    Wachowiak R, Kaifi J, Schwarzenbach H, Yekebas E, Merkert P, Schurr P, Hansen B, Reichelt U, Strate T, Pantel K, Izbicki JR.
    Diagn Mol Pathol; 2007 Sep; 16(3):174-8. PubMed ID: 17721326
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Detection and characterization of circulating microsatellite-DNA in blood of patients with breast cancer.
    Schwarzenbach H, Müller V, Stahmann N, Pantel K.
    Ann N Y Acad Sci; 2004 Jun; 1022():25-32. PubMed ID: 15251935
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Clonality analysis of multiple hepatocellular carcinomas by loss of heterozygosity pattern determined by chromosomes 16q and 13q.
    Lin YW, Lee HS, Chen CH, Huang GT, Lee PH, Sheu JC.
    J Gastroenterol Hepatol; 2005 Apr; 20(4):536-46. PubMed ID: 15836701
    [Abstract] [Full Text] [Related]

  • 6. Clinical value of loss of heterozygosity in serum microsatellite DNA of patients with gastrointestinal stromal tumors.
    Schurr PG, Oikonomou D, Kaifi JT, Merkert P, Wolter S, Kleinhans H, Reichelt U, Mann O, Gawad KA, Strate T, Yekebas EF, Izbicki JR.
    J Clin Gastroenterol; 2009 Jan; 43(1):27-35. PubMed ID: 18469721
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. DNA methylation alterations in the pancreatic juice of patients with suspected pancreatic disease.
    Matsubayashi H, Canto M, Sato N, Klein A, Abe T, Yamashita K, Yeo CJ, Kalloo A, Hruban R, Goggins M.
    Cancer Res; 2006 Jan 15; 66(2):1208-17. PubMed ID: 16424060
    [Abstract] [Full Text] [Related]

  • 10. Limits of CEA and ferritin in the diagnosis of pancreatic cancer.
    Plebani M, Fabris C, Basso D, Del Favero G, Angonese C, Leandro G, Di Mario F, Burlina A, Naccarato R.
    Int J Pancreatol; 1988 Jan 15; 3 Suppl 1():S113-7. PubMed ID: 3209864
    [Abstract] [Full Text] [Related]

  • 11. Detection of the pancreas-specific gene in the peripheral blood of patients with pancreatic carcinoma.
    Kuroki T, Tomioka T, Tajima Y, Inoue K, Ikematsu Y, Ichinose K, Furui J, Kanematsu T.
    Br J Cancer; 1999 Sep 15; 81(2):350-3. PubMed ID: 10496364
    [Abstract] [Full Text] [Related]

  • 12. Microsatellite analysis of serum DNA in patients with oral squamous cell carcinoma.
    Kakimoto Y, Yamamoto N, Shibahara T.
    Oncol Rep; 2008 Nov 15; 20(5):1195-200. PubMed ID: 18949421
    [Abstract] [Full Text] [Related]

  • 13. Differential methylation of cell-free circulating DNA among patients with pancreatic cancer versus chronic pancreatitis.
    Liggett T, Melnikov A, Yi QL, Replogle C, Brand R, Kaul K, Talamonti M, Abrams RA, Levenson V.
    Cancer; 2010 Apr 01; 116(7):1674-80. PubMed ID: 20143430
    [Abstract] [Full Text] [Related]

  • 14. The detection of oesophageal adenocarcinoma by serum microsatellite analysis.
    Eisenberger CF, Stoecklein NH, Jazra S, Hosch SB, Peiper M, Scheunemann P, Am Esch JS, Knoefel WT.
    Eur J Surg Oncol; 2006 Nov 01; 32(9):954-60. PubMed ID: 16584865
    [Abstract] [Full Text] [Related]

  • 15. Neopterin--a potential factor for differentiation between pancreatic cancer and chronic pancreatitis.
    Piecuch J, Rudzki M, Orkisz W, Swietochowska E, Wielkoszyński T, Waniczek D, Arendt J, Sosada K, Zurawiński W, Ładny JR.
    Hepatogastroenterology; 2008 Nov 01; 55(81):258-61. PubMed ID: 18507120
    [Abstract] [Full Text] [Related]

  • 16. Tumor marker M2-pyruvate-kinase in differential diagnosis of chronic pancreatitis and pancreatic cancer.
    Novotný I, Dítĕ P, Dastych M, Záková A, Trna J, Novotná H, Nechutová H.
    Hepatogastroenterology; 2008 Nov 01; 55(85):1475-7. PubMed ID: 18795715
    [Abstract] [Full Text] [Related]

  • 17. [Role of serum markers and or various clinical parameters in the diagnosis of pancreatic carcinoma].
    Meggiato T, Basso D, Piccoli A, Del Favero G, Fogar P, Panozzo MP, Scalon P, Fabris C, Angonese C, Faggian D.
    Ann Ital Med Int; 1989 Nov 01; 4(4):367-72. PubMed ID: 2487791
    [Abstract] [Full Text] [Related]

  • 18. New MUC1 serum immunoassay differentiates pancreatic cancer from pancreatitis.
    Gold DV, Modrak DE, Ying Z, Cardillo TM, Sharkey RM, Goldenberg DM.
    J Clin Oncol; 2006 Jan 10; 24(2):252-8. PubMed ID: 16344318
    [Abstract] [Full Text] [Related]

  • 19. Soluble interleukin-2 receptor: a new marker in pancreatic adenocarcinoma?
    Rabitti PG, Pacelli L, Uomo G, Laccetti M, Spada OA, Esposito G, Visconti M.
    Minerva Gastroenterol Dietol; 1994 Sep 10; 40(3):101-3. PubMed ID: 7948318
    [Abstract] [Full Text] [Related]

  • 20. Proteomic analysis of chronic pancreatitis and pancreatic adenocarcinoma.
    Crnogorac-Jurcevic T, Gangeswaran R, Bhakta V, Capurso G, Lattimore S, Akada M, Sunamura M, Prime W, Campbell F, Brentnall TA, Costello E, Neoptolemos J, Lemoine NR.
    Gastroenterology; 2005 Nov 10; 129(5):1454-63. PubMed ID: 16285947
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.